VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| 格式: | Conference item |
| 出版: |
American Society of Clinical Oncology
2018
|
| _version_ | 1826299336586166272 |
|---|---|
| author | Redchenko, I Cappuccini, F Pollock, E Bryant, R Carter, L Verrill, C Hollidge, J Goodwin, L Harrop, R Romero, P Vigano, S Evans, T Catto, J Hamdy, F Hill, A |
| author_facet | Redchenko, I Cappuccini, F Pollock, E Bryant, R Carter, L Verrill, C Hollidge, J Goodwin, L Harrop, R Romero, P Vigano, S Evans, T Catto, J Hamdy, F Hill, A |
| author_sort | Redchenko, I |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T05:00:23Z |
| format | Conference item |
| id | oxford-uuid:d811b39f-a8f4-4fb4-a5b7-b513a90fdc25 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T05:00:23Z |
| publishDate | 2018 |
| publisher | American Society of Clinical Oncology |
| record_format | dspace |
| spelling | oxford-uuid:d811b39f-a8f4-4fb4-a5b7-b513a90fdc252022-03-27T08:45:44ZVANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancerConference itemhttp://purl.org/coar/resource_type/c_5794uuid:d811b39f-a8f4-4fb4-a5b7-b513a90fdc25Symplectic Elements at OxfordAmerican Society of Clinical Oncology2018Redchenko, ICappuccini, FPollock, EBryant, RCarter, LVerrill, CHollidge, JGoodwin, LHarrop, RRomero, PVigano, SEvans, TCatto, JHamdy, FHill, A |
| spellingShingle | Redchenko, I Cappuccini, F Pollock, E Bryant, R Carter, L Verrill, C Hollidge, J Goodwin, L Harrop, R Romero, P Vigano, S Evans, T Catto, J Hamdy, F Hill, A VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer |
| title | VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer |
| title_full | VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer |
| title_fullStr | VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer |
| title_full_unstemmed | VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer |
| title_short | VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer |
| title_sort | vance first in human phase i study of a novel chadox1 mva 5t4 vaccine in low and intermediate risk prostate cancer |
| work_keys_str_mv | AT redchenkoi vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT cappuccinif vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT pollocke vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT bryantr vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT carterl vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT verrillc vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT hollidgej vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT goodwinl vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT harropr vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT romerop vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT viganos vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT evanst vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT cattoj vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT hamdyf vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer AT hilla vancefirstinhumanphaseistudyofanovelchadox1mva5t4vaccineinlowandintermediateriskprostatecancer |